The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Axitinib in advanced renal cell carcinoma: Outcomes following pazopanib or sunitinib.
 
Jennifer Laskey
Honoraria - GlaxoSmithKline; Pfizer
Consulting or Advisory Role - GlaxoSmithKline; Pfizer
 
Balaji Venugopal
Consulting or Advisory Role - Pfizer
 
Nicola Thomson
No Relationships to Disclose
 
Roisin O'Donoghue
No Relationships to Disclose
 
Robert J. Jones
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Dendreon; GlaxoSmithKline; Janssen-Ortho; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)